Bachem Holding AG

    Jurisdiction
    Switzerland
    LEI
    506700S81111XI7TG884
    ISIN
    CH1176493729 (BANB.SW)
    Sectors
    1. Basic Materials
    2. Chemicals

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €59.07 9.2% overvalued
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. Read full profile

    Fundamentals

    Net revenue
    €1.34B
    Gross margin
    31.1%
    EBIT
    €313.67M
    EBIT margin
    23.3%
    Net income
    €265.18M
    Net margin
    19.7%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.02B -23.9% €187.61M -29.3%
    €1.22B +19.4% €228.99M +22.1%
    €1.39B +13.6% €250.40M +9.3%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    CHF 0.85
    Ex date
    Payment date
    Dividend payout ratio
    36.6%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications